eMed Population Health Announces Tom Finn as New Executive Vice President of Sales to Drive Growth
On November 2, 2026, eMed Population Health made a significant announcement regarding the transformation of its leadership team, naming Tom Finn as the Executive Vice President of Sales. Finn steps into this high-profile role with an impressive background, bringing over 20 years of extensive experience in enterprise sales, health plan operations, and commercial growth. This appointment signals eMed's strategic move to enhance its enterprise sales organization and aims to accelerate the adoption of its clinically managed GLP-1 programs by major employers across the nation.
In his new capacity, Finn will assume complete accountability for devising and executing innovative sales strategies meant to spur new business ventures and enhance revenue growth. His focus will be on engaging with the largest employers in the country, as well as collaborating with employee benefits brokers and consultants who guide these firms in optimizing their benefit offerings. Finn aims to strengthen the existing partnerships to foster further growth within the employer sector.
Linda Yaccarino, the CEO of eMed Population Health, expressed enthusiasm about Finn's appointment, stating, "Tom is a transformational leader, and he's joining eMed at an incredibly important moment for healthcare. Our rapid growth with enterprise employers reflects the power of our clinical model, and we are ready for the next stage." Yaccarino also emphasized that Finn’s rich experience building and leading high-performance healthcare teams will be instrumental in expanding the company’s reach and deepening its relationships with employers across the country.
Before eMed, Finn was successful in building the sales team and creating a national broker distribution network for Onsera, a company specializing in clinically managed GLP-1 solutions. His previous roles also include being the founding CEO of LeggUP, a behavioral health and well-being platform, and holding senior leadership positions in two of the country's leading health benefits organizations, Aetna and Elevance Health. His years of involvement at a high level in health plans and employer benefits gives him a unique perspective on the urgent needs of employers seeking solutions that enhance health outcomes while managing rising healthcare costs.
"Employers are looking for solutions that can improve health outcomes while helping manage rising healthcare costs, and eMed is uniquely positioned to meet that need," Finn explained. "The company has developed a differentiated platform, proven clinical results, and strong employer relationships. I'm excited to build on that foundation and help bring eMed's clinically managed GLP-1 programs to more organizations nationwide."
With Finn officially joining eMed on November 2 and reporting directly to CEO Linda Yaccarino, he is set to commence this ambitious journey aimed at redefining health benefits for employers through innovative programs. This pivotal move adds momentum to eMed's mission of transforming healthcare via technology-driven solutions that not only improve access but also empower individuals in taking charge of their health.
eMed Population Health is dedicated to leveraging advanced technology to make healthcare more accessible and effective. Its combination of telehealth, diagnostics, care navigation, and population health capabilities equips consumers, employers, payers, and healthcare organizations with the tools necessary to improve health outcomes while dismantling barriers to care. As Finn embarks on this new role, the industry watches closely to see how his leadership will further the enhancements to employee care and corporate wellness programs within the marketplace.